Michele Cavo

CONFERENZA INIZIALE: 25 febbraio 2015 - Aula Prodi Dipartimento Storia Culture e Civiltà ORE 16.00 - 19.00

Giuliana Gemelli, Guido Biasco, Gioacchino Pagliaro, 2015 .

Proteasome inhibitors in multiple myeloma: 10 years later.

Michele Cavo, Philippe Moreau, A. Palumbo, 2012, Blood.

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD)

Gastone Castellani, Daniel Remondini, Giovanni Martinelli, 2015, Oncotarget.

Comparison of Two Different Therapeutic Regimens with Azacitidine and Lenalidomide (Combined versus Sequential) in Higher-Risk Myelodysplastic Syndromes. Update of Long-Term Results of a Randomized Phase II Multicenter Study

Michele Cavo, Patrizia Tosi, Marco Gobbi, 2018, Blood.

Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study

Michele Cavo, Patrizia Tosi, Marco Gobbi, 2016 .

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.

Christian Jacques, Nizar Bahlis, Michele Cavo, 2014, The New England journal of medicine.

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.

Bart Barlogie, Monika Engelhardt, Niels Abildgaard, 2017, The Lancet. Oncology.

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation.

Michele Cavo, Hermann Einsele, Philippe Moreau, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.

Sante Tura, Michele Cavo, Patrizia Tosi, 2004, Haematologica.

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.

Jian Hou, Bart Barlogie, Michele Cavo, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Hans Erik Johnsen, Giampaolo Merlini, Robert A Kyle, 2014, The Lancet. Oncology.